ClinConnect ClinConnect Logo
Search / Trial NCT06890546

Nigella Sativa Supplementation in Hyperlipidemia Treatment

Launched by ISTANBUL BILGI UNIVERSITY · Mar 21, 2025

Trial Information

Current as of April 23, 2025

Completed

Keywords

Nigella Sativa Obesity Medical Nutrition Therapy

ClinConnect Summary

This research, which is a randomized controlled intervention study, was conducted between June 2023 and February 2024 with adult individuals with a BMI\>25 kg/m2 who applied to the Cardiology Polyclinic of Karamürsel State Hospital and were referred to a nutrition and diet specialist after being diagnosed with hyperlipidemia according to AHA criteria by the physician.

Sample Selection and Randomization The sample size of the study was calculated using the G-Power 3.1.9 analysis program with a medium effect size (d=0.60), 90% power, α: 0.05 and 1-β: 0.95, with a minimum of 32 people in each...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults individuals who were diagnosed hyperlipidemia
  • Individuals suitable for taking Nigella satvia supplement
  • Individuals BMI\>25 kg/m2
  • Exclusion Criteria:
  • Chronic liver disease,
  • Chronic kidney disease,
  • Heart failure, infarction or cerebrovascular disease,
  • Pregnant and breastfeeding women,
  • Severe psychiatric disorders,
  • Oncological diseases,
  • Individuals using medications that could interact with black seed oil (anticoagulant, antihypertensive, etc.)
  • Individuals using antilipidemic or anticholesterolemic medications
  • Individuals did not do heavy exercise
  • Individuals using any nutritional supplement
  • Individuals have a known history of allergy
  • Individuals did not consume alcohol regularly
  • Individuals with special dietary needs

Trial Officials

Hande Seven Avuk, PhD

Principal Investigator

İstanbul Bilgi University

About Istanbul Bilgi University

Istanbul Bilgi University is a prominent educational and research institution in Turkey, dedicated to advancing knowledge across various disciplines, including health sciences. With a commitment to excellence in research and innovation, the university actively engages in clinical trials aimed at enhancing healthcare outcomes. By fostering collaborations with healthcare professionals and leveraging its academic expertise, Istanbul Bilgi University strives to contribute to the development of effective medical interventions and evidence-based practices, ultimately improving patient care and advancing public health.

Locations

İstanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported